Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1984 2
1986 1
1987 4
1988 1
1989 5
1990 3
1991 2
1992 5
1993 1
1994 3
1995 12
1996 3
1997 2
1998 4
1999 3
2000 6
2001 2
2002 7
2003 6
2004 7
2005 2
2006 7
2007 4
2008 4
2009 10
2010 8
2011 17
2012 15
2013 18
2014 20
2015 18
2016 13
2017 18
2018 19
2019 13
2020 28
2021 21
2022 22
2023 30
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Retinitis pigmentosa 30"
Page 1
Non-syndromic retinitis pigmentosa.
Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, Hoyng CB, Roepman R, Klevering BJ. Verbakel SK, et al. Prog Retin Eye Res. 2018 Sep;66:157-186. doi: 10.1016/j.preteyeres.2018.03.005. Epub 2018 Mar 27. Prog Retin Eye Res. 2018. PMID: 29597005 Free article. Review.
Retinitis pigmentosa (RP) encompasses a group of inherited retinal dystrophies characterized by the primary degeneration of rod and cone photoreceptors. RP is a leading cause of visual disability, with a worldwide prevalence of 1:4000. Although the majority of RP ca …
Retinitis pigmentosa (RP) encompasses a group of inherited retinal dystrophies characterized by the primary degeneration of ro …
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
Haqq AM, Chung WK, Dollfus H, Haws RM, Martos-Moreno GÁ, Poitou C, Yanovski JA, Mittleman RS, Yuan G, Forsythe E, Clément K, Argente J. Haqq AM, et al. Lancet Diabetes Endocrinol. 2022 Dec;10(12):859-868. doi: 10.1016/S2213-8587(22)00277-7. Epub 2022 Nov 7. Lancet Diabetes Endocrinol. 2022. PMID: 36356613 Free PMC article. Clinical Trial.
Patients aged 6 years or older were included if they had a clinical diagnosis of Bardet-Biedl syndrome or Alstrom syndrome and obesity (defined as BMI >97th percentile for age and sex for those aged 6-15 years and 30 kg/m(2) for those aged 16 years). Patients were rando …
Patients aged 6 years or older were included if they had a clinical diagnosis of Bardet-Biedl syndrome or Alstrom syndrome and obesity (defi …
Transcriptomic analysis of the ocular posterior segment completes a cell atlas of the human eye.
Monavarfeshani A, Yan W, Pappas C, Odenigbo KA, He Z, Segrè AV, van Zyl T, Hageman GS, Sanes JR. Monavarfeshani A, et al. Proc Natl Acad Sci U S A. 2023 Aug 22;120(34):e2306153120. doi: 10.1073/pnas.2306153120. Epub 2023 Aug 11. Proc Natl Acad Sci U S A. 2023. PMID: 37566633 Free PMC article.
Defects in each of these tissues are associated with blinding diseases-for example, glaucoma (ONH and PPS), optic neuritis (ON), retinitis pigmentosa (RPE), and age-related macular degeneration (RPE and choroid). ...
Defects in each of these tissues are associated with blinding diseases-for example, glaucoma (ONH and PPS), optic neuritis (ON), retiniti …
Retinitis pigmentosa: recent advances and future directions in diagnosis and management.
Fahim A. Fahim A. Curr Opin Pediatr. 2018 Dec;30(6):725-733. doi: 10.1097/MOP.0000000000000690. Curr Opin Pediatr. 2018. PMID: 30234647 Review.
PURPOSE OF REVIEW: Retinitis pigmentosa is a group of genetically diverse inherited blinding disorders for which there are no treatments. ...RECENT FINDINGS: This review will highlight the use of retinal imaging to measure progression of disease, next-generation seq …
PURPOSE OF REVIEW: Retinitis pigmentosa is a group of genetically diverse inherited blinding disorders for which there are no …
Cone rod dystrophies.
Hamel CP. Hamel CP. Orphanet J Rare Dis. 2007 Feb 1;2:7. doi: 10.1186/1750-1172-2-7. Orphanet J Rare Dis. 2007. PMID: 17270046 Free PMC article. Review.
CRDs are characterized by retinal pigment deposits visible on fundus examination, predominantly localized to the macular region. In contrast to typical retinitis pigmentosa (RP), also called the rod cone dystrophies (RCDs) resulting from the primary loss in rod phot …
CRDs are characterized by retinal pigment deposits visible on fundus examination, predominantly localized to the macular region. In contrast …
Diabetes mellitus in Bardet Biedl syndrome.
Pomeroy J, Offenwanger KM, Timmler T. Pomeroy J, et al. Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):27-31. doi: 10.1097/MED.0000000000000788. Epub 2022 Dec 8. Curr Opin Endocrinol Diabetes Obes. 2023. PMID: 36476576 Review.
Stem cell therapy for inherited retinal diseases: a systematic review and meta-analysis.
Chen X, Xu N, Li J, Zhao M, Huang L. Chen X, et al. Stem Cell Res Ther. 2023 Oct 5;14(1):286. doi: 10.1186/s13287-023-03526-x. Stem Cell Res Ther. 2023. PMID: 37798796 Free PMC article. Review.
This study aims to quantitatively examine the effectiveness and safety of stem cell therapy for patients with IRDs, including retinitis pigmentosa and Stargardt disease (STGD). METHODS: We searched PubMed, EMBASE, Web of Science, Cochrane Library databases, and the …
This study aims to quantitatively examine the effectiveness and safety of stem cell therapy for patients with IRDs, including retinitis …
Retinitis pigmentosa-associated anterior subcapsular cataract: morphological features and visual performance.
Hou M, Bao X, Liu L, Ding Y, Luo F, Wu M. Hou M, et al. Int Ophthalmol. 2021 Nov;41(11):3631-3639. doi: 10.1007/s10792-021-01935-6. Epub 2021 Jun 27. Int Ophthalmol. 2021. PMID: 34180018
PURPOSE: To investigate the morphological features and surgical outcomes of retinitis pigmentosa (RP)-associated anterior subcapsular cataract (ASC). ...RESULTS: The mean age was 52.1 13.7 years, and the 41-50-year group had the best BCVA. 13.5% of eyes had BCVA bet …
PURPOSE: To investigate the morphological features and surgical outcomes of retinitis pigmentosa (RP)-associated anterior subc …
Corneal characteristics in patients with retinitis pigmentosa.
Zeki Fikret C, Ucgun NI, Karaca EE, Evren Kemer O. Zeki Fikret C, et al. Photodiagnosis Photodyn Ther. 2023 Jun;42:103554. doi: 10.1016/j.pdpdt.2023.103554. Epub 2023 Apr 6. Photodiagnosis Photodyn Ther. 2023. PMID: 37030435
BACKGROUND: To evaluate corneal topography and specular microscopic findings in patients with retinitis pigmentosa. METHODS: One hundred and two eyes of 51 patients with retinitis pigmentosa and 60 eyes of 30 healty subjects were included in our …
BACKGROUND: To evaluate corneal topography and specular microscopic findings in patients with retinitis pigmentosa. METHODS: O …
The Argus(®) II Retinal Prosthesis System.
Luo YH, da Cruz L. Luo YH, et al. Prog Retin Eye Res. 2016 Jan;50:89-107. doi: 10.1016/j.preteyeres.2015.09.003. Epub 2015 Sep 25. Prog Retin Eye Res. 2016. PMID: 26404104 Review.
As such it has entered the commercial market as a treatment for patients with profound vision loss from end-stage outer retinal disease, predominantly retinitis pigmentosa. To date, over 100 devices have been implanted worldwide, representing the largest group of pa …
As such it has entered the commercial market as a treatment for patients with profound vision loss from end-stage outer retinal disease, pre …
334 results